Cefditoren Pivoxil

头孢托仑酯

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefditoren Pivoxil
Drug Alias NameCefditoreno头孢妥仑酯头孢妥仑匹酯Cefditorenum头孢地妥仑酯 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsColitis, UlcerativeUrinary Tract InfectionsGram-Positive Bacterial Infections +[4] 
Global Approved IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2001/08/29
Country/TerritoryUnited StatesSpainGreece +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Seika Pharmatech Co Ltd
Inactive CompaniesTedec Meiji Farma SaVansen Pharma Inc
Active IndicationsColitis, Ulcerative
Inactive IndicationsUrinary Tract InfectionsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeJ01DD16
Related LinksWikipediaDrugBankKEGG